Overall, our data reveal that CDK5 activation occurs after RET activation by GDNF stimulation, suggesting that CDK5 may be a potential downstream of RET protein in GDNF-induced human medullary thyroid cancer cell proliferation. Here, CDK5 is linked to medullary thyroid gland carcinoma.